Physician profile
David Hood
NPI 1831303064
$1,052.37
in general payments reported to CMS, 2019-2025
13 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2021: $219 · 2022: $17.45 · 2023: $143 · 2024: $238 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $228.26 | 2019-2023 | |
| Neurent Medical Limited | $169.11 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Stryker Corporation | $117.52 | 2021 | |
| Medtronic, INC. | $99.54 | 2025 | Propel, Nuvent |
| Inspire Medical Systems, INC. | $77.88 | 2023 | Inspire |
| Intersect Ent, INC. | $75.66 | 2021 | |
| Glaxosmithkline, LLC. | $55.35 | 2025 | Nucala |
| Integra Lifesciences Corporation | $52.93 | 2023-2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Baxter Healthcare | $43.69 | 2019 | |
| Senseonics, Incorporated | $38.00 | 2019 | |
| Optinose US, INC. | $36.08 | 2019-2025 | |
| Acclarent, INC | $32.75 | 2024 | Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $25.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.